These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38158168)

  • 1. Autoimmune and auto-inflammatory adverse events after COVID-19 vaccination in the United States.
    Kim SJ; Rhee TG; Shim SR
    Clin Immunol; 2024 Feb; 259():109882. PubMed ID: 38158168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS).
    Shin J; Shim SR; Lee J; Ryu HS; Kim JY
    Front Public Health; 2023; 11():1338862. PubMed ID: 38269374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
    Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
    JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.
    Mangat HS; Musah A; Luedtke S; Syed AA; Maramattom BV; Maruthanal J; Bosman A; Kostkova P
    Front Public Health; 2022; 10():972464. PubMed ID: 36311588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.
    Rosenblum HG; Gee J; Liu R; Marquez PL; Zhang B; Strid P; Abara WE; McNeil MM; Myers TR; Hause AM; Su JR; Markowitz LE; Shimabukuro TT; Shay DK
    Lancet Infect Dis; 2022 Jun; 22(6):802-812. PubMed ID: 35271805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
    Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
    J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic Neuritis After COVID-19 Vaccination: An Analysis of the Vaccine Adverse Event Reporting System.
    Jaffry M; Aftab OM; Mostafa FB; Faiz I; Jaffry K; Mandava K; Rosario S; Jedidi K; Khan H; Souayah N
    J Neuroophthalmol; 2023 Dec; 43(4):499-503. PubMed ID: 37314860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults.
    Harris DA; Hayes KN; Zullo AR; Mor V; Chachlani P; Deng Y; McCarthy EP; Djibo DA; McMahill-Walraven CN; Gravenstein S
    JAMA Netw Open; 2023 Aug; 6(8):e2326852. PubMed ID: 37531110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing for COVID-19 vaccine safety surveillance: A United States perspective.
    Haynes K
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1529-1531. PubMed ID: 32978861
    [No Abstract]   [Full Text] [Related]  

  • 11. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
    Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
    Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data.
    Li Y; Lundin SK; Li J; Tao W; Dang Y; Chen Y; Tao C
    Expert Rev Vaccines; 2024; 23(1):53-59. PubMed ID: 38063069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
    See I; Lale A; Marquez P; Streiff MB; Wheeler AP; Tepper NK; Woo EJ; Broder KR; Edwards KM; Gallego R; Geller AI; Jackson KA; Sharma S; Talaat KR; Walter EB; Akpan IJ; Ortel TL; Urrutia VC; Walker SC; Yui JC; Shimabukuro TT; Mba-Jonas A; Su JR; Shay DK
    Ann Intern Med; 2022 Apr; 175(4):513-522. PubMed ID: 35038274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.
    Mangat HS; Rippon B; Reddy NT; Syed AA; Maruthanal JM; Luedtke S; Puthumana JJ; Srivatsa A; Bosman A; Kostkova P
    PLoS One; 2023; 18(2):e0281993. PubMed ID: 36800368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database.
    Kim S; Bea S; Choe SA; Choi NK; Shin JY
    Eur J Clin Pharmacol; 2024 Mar; 80(3):445-453. PubMed ID: 38212538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reports of COVID-19 Vaccine Adverse Events in Predominantly Republican vs Democratic States.
    Asch DA; Luo C; Chen Y
    JAMA Netw Open; 2024 Mar; 7(3):e244177. PubMed ID: 38551560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
    Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
    JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports.
    Sadat Larijani M; Doroud D; Banifazl M; Karami A; Bavand A; Ashrafian F; Ramezani A
    Eur J Med Res; 2023 Nov; 28(1):542. PubMed ID: 38008729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study.
    Mesina FZ; Sapinoso FAD; De Castro JAV; Vaswani PPM; Sy CES; Oquendo RAA; Lirasan MRA
    Vaccine; 2023 May; 41(23):3550-3555. PubMed ID: 37150619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023.
    Moro PL; Carlock G; Fifadara N; Habenicht T; Zhang B; Strid P; Marquez P
    Vaccine; 2024 Apr; 42(9):2380-2384. PubMed ID: 38462432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.